Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8656942 | Atherosclerosis | 2018 | 28 Pages |
Abstract
In RCTs with statin treatment, the reduction of VTE risk was only partially related to LDL-c reduction and the benefit was larger than that observed for atherothrombotic risk. Further RCTs are warranted to clarify the relationship between statin, lipid modifications, and VTE risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Francesco Zaccardi, Setor K. Kunutsor, Samuel Seidu, Melanie J. Davies, Kamlesh Khunti,